Five Oceans Advisors Astrazeneca PLC Transaction History
Five Oceans Advisors
- $188 Million
- Q1 2025
A detailed history of Five Oceans Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Five Oceans Advisors holds 7,591 shares of AZN stock, worth $544,957. This represents 0.3% of its overall portfolio holdings.
Number of Shares
7,591
Previous 9,936
23.6%
Holding current value
$544,957
Previous $651,000
14.44%
% of portfolio
0.3%
Previous 0.33%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,386Shares Held
478MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.33 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.94 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.69 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.72 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $222B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...